/Bio-Techne%20Corp%20logo%20and%20data-by%20Piotr%20Swat%20via%20Shutterstock.jpg)
Minneapolis, Minnesota-based Bio-Techne Corporation (TECH) develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets. With a market cap of $12.2 billion, Bio-Techne operates through Protein Sciences, and Diagnostics and Genomics segments.
Companies worth $10 billion or more are generally described as "large-cap stocks," Bio-Techne fits right into that category, with its market cap exceeding this threshold, reflecting its substantial size, influence, and dominance in the biotechnology industry. Its operations span 34 locations across the United States, Europe, and Indo-Pacific.